Jeffrey Tice, MD

Jeffrey Tice, MD

Associate Professor, Department of Medicine (General Internal Medicine), UCSF

Phone: (844) 727-8273 (appts)
Box 0320, UCSF
San Francisco, CA 94143-0320

UCSF Profiles | Physician Referral Directory

Cancer Center Membership

Associate Member » Breast Oncology


Dartmouth College, Hanover, NH, BA, 06/1983, Math; Philosophy
San Francisco State University, 05/1989, Pre-medical classed
University of California, San Francisco, MD, 06/1994, Medicine
University of California, San Francisco, 06/1997, Internal Medicine
University of California, San Francisco, Postdoctoral, 06/1999, Research/Epidmiology

Professional Experience

  • 1984-1986
    Peace Corps Volunteer, Bangassou, Central African Republic
  • 1987 - 1992
    Programmer/Analyst III, Department of Epidemiology, University of California, San Francisco
  • 1999-2004
    Assistant Adjunct Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
  • 2005-2011
    Assistant Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
  • 2012-present
    Associate Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco

Honors & Awards

  • 2013
    UCSF Research Mentoring Award
  • 2009
    Society of General Internal Medicine- CA Region- Outstanding Clinician Investigator Award
  • 2003
    Robert Crede Award for Clinical Research, UCSF Division of General Internal Medicine
  • 2002-2004
    Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Faculty Scholar
  • 1994
    Alpha Omega Alpha, UCSF
  • 1990-1994
    Regents Scholarship, UCSF
  • 1983
    Summa Cum Laude, Dartmouth College
  • 1982
    Phi Beta Kappa, Dartmouth College
  • 1979-1983
    Rufous Choate Scholar, Dartmouth College
  • 1979-1983
    IBM Thomas J. Watson Scholar

Selected Publications

  1. Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 Jan; 109(5).
    View on PubMed
  2. Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer. J Natl Cancer Inst. 2017 May; 109(5).
    View on PubMed
  3. Whittington MD, McQueen RB, Ollendorf DA, Tice JA, Chapman RH, Pearson SD, Campbell JD. Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis. Ann Allergy Asthma Immunol. 2016 Dec 03.
    View on PubMed
  4. Reed SJ, Shore KK, Tice JA. Effectiveness and Value of Integrating Behavioral Health Into Primary Care. JAMA Intern Med. 2016 May 1; 176(5):691-2.
    View on PubMed
  5. Dallal CM, Lacey JV, Pfeiffer RM, Bauer DC, Falk RT, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Veenstra TD, Xu X, Brinton LA. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B~FIT Cohort. Horm Cancer. 2016 Feb; 7(1):49-64.
    View on PubMed
  6. Tice JA, Kazi DS, Pearson SD. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value. JAMA Intern Med. 2016 Jan 1; 176(1):107-8.
    View on PubMed
  7. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan 1; 176(1):65-73.
    View on PubMed
  8. Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Dec; 24(6):758-66.
    View on PubMed
  9. Tice JA, Chahal HS, Ollendorf DA. Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report. JAMA Intern Med. 2015 Sep; 175(9):1559-60.
    View on PubMed
  10. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015 May; 107(5).
    View on PubMed
  11. Ollendorf DA, Tice JA, Pearson SD. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection. JAMA Intern Med. 2014 Jul; 174(7):1170-1.
    View on PubMed
  12. Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Aug; 106(8).
    View on PubMed
  13. Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS. A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1245-53.
    View on PubMed
  14. McMahon LF, Beyth RJ, Burger A, Chopra V, Feldstein D, Korenstein D, Subramanian U, Sussman J, Petty B, Tice J. Enhancing patient-centered care: SGIM and choosing wisely. J Gen Intern Med. 2014 Mar; 29(3):432-3.
    View on PubMed
  15. Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014 May; 23(5):420-7.
    View on PubMed
  16. Tice JA, Sellke FW, Schaff HV. Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum. J Thorac Cardiovasc Surg. 2014 Aug; 148(2):482-91.e6.
    View on PubMed
  17. Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV, Cauley JA, Hue TF, Lacroix A, Falk RT, Pfeiffer RM, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis. 2014 Feb; 35(2):346-55.
    View on PubMed
  18. Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013 Jul 17; 105(14):1043-9.
    View on PubMed
  19. Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer. 2013 Feb; 20(1):151-60.
    View on PubMed
  20. Sawaya GF, Tice JA. Evidence at the point of practice change: lung cancer screening. Arch Intern Med. 2012 Oct 8; 172(18):1415-7.
    View on PubMed

Go to UCSF Profiles, powered by CTSI